Selected research
Market Analysis & Forecast
Global Chinese Medicine Testing Market Analysis and Forecast 2026-2032
Market perspective
The global Chinese Medicine Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Chinese Medicine Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Chinese Medicine Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Chinese Medicine Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Chinese Medicine Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Chinese Medicine Testing include Castco Testing Centre, Hong Kong Productivity Council (HKPC), SGS, Lab Test One, CMA Testing, Agilent Technologies, Hong Kong Standards and Testing Centre and Nuherbs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Chinese Medicine Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Chinese Medicine Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Chinese Medicine Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Chinese Medicine Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chinese Medicine Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Chinese Medicine Testing revenue, projected growth trends, production technology, application and end-user industry.
Chinese Medicine Testing Segment by Company
Castco Testing Centre
Hong Kong Productivity Council (HKPC)
SGS
Lab Test One
CMA Testing
Agilent Technologies
Hong Kong Standards and Testing Centre
Nuherbs
Chinese Medicine Testing Segment by Type
Chinese Herbal Medicine
Chinese Patent Medicine
Chinese Medicine Testing Segment by Application
Laboratory
Factory
Chinese Medicine Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Chinese Medicine Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Chinese Medicine Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chinese Medicine Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chinese Herbal Medicine
- Chinese Patent Medicine
Applications
- Laboratory
- Factory
Companies covered
- Castco Testing Centre
- Hong Kong Productivity Council (HKPC)
- SGS
- Lab Test One
- CMA Testing
- Agilent Technologies
- Hong Kong Standards and Testing Centre
- Nuherbs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Chinese Medicine Testing Market by Type
- 1.2.1 Global Chinese Medicine Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Chinese Herbal Medicine
- 1.2.3 Chinese Patent Medicine
- 1.3 Chinese Medicine Testing Market by Application
- 1.3.1 Global Chinese Medicine Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Laboratory
- 1.3.3 Factory
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Chinese Medicine Testing Market Dynamics
- 2.1 Chinese Medicine Testing Industry Trends
- 2.2 Chinese Medicine Testing Industry Drivers
- 2.3 Chinese Medicine Testing Industry Opportunities and Challenges
- 2.4 Chinese Medicine Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Chinese Medicine Testing Market Perspective (2021-2032)
- 3.2 Global Chinese Medicine Testing Growth Trends by Region
- 3.2.1 Global Chinese Medicine Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Chinese Medicine Testing Market Size by Region (2021-2026)
- 3.2.3 Global Chinese Medicine Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Chinese Medicine Testing Revenue by Players
- 4.1.1 Global Chinese Medicine Testing Revenue by Players (2021-2026)
- 4.1.2 Global Chinese Medicine Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Chinese Medicine Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Chinese Medicine Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Chinese Medicine Testing Key Players Headquarters & Area Served
- 4.4 Global Chinese Medicine Testing Players, Product Type & Application
- 4.5 Global Chinese Medicine Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Chinese Medicine Testing Market CR5 and HHI
- 4.6.3 2025 Chinese Medicine Testing Tier 1, Tier 2, and Tier 3
5 Chinese Medicine Testing Market Size by Type
- 5.1 Global Chinese Medicine Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Chinese Medicine Testing Revenue by Type (2021-2032)
- 5.3 Global Chinese Medicine Testing Revenue Market Share by Type (2021-2032)
6 Chinese Medicine Testing Market Size by Application
- 6.1 Global Chinese Medicine Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Chinese Medicine Testing Revenue by Application (2021-2032)
- 6.3 Global Chinese Medicine Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Castco Testing Centre
- 7.1.1 Castco Testing Centre Company Information
- 7.1.2 Castco Testing Centre Business Overview
- 7.1.3 Castco Testing Centre Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 Castco Testing Centre Chinese Medicine Testing Product Portfolio
- 7.1.5 Castco Testing Centre Recent Developments
- 7.2 Hong Kong Productivity Council (HKPC)
- 7.2.1 Hong Kong Productivity Council (HKPC) Company Information
- 7.2.2 Hong Kong Productivity Council (HKPC) Business Overview
- 7.2.3 Hong Kong Productivity Council (HKPC) Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 Hong Kong Productivity Council (HKPC) Chinese Medicine Testing Product Portfolio
- 7.2.5 Hong Kong Productivity Council (HKPC) Recent Developments
- 7.3 SGS
- 7.3.1 SGS Company Information
- 7.3.2 SGS Business Overview
- 7.3.3 SGS Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 SGS Chinese Medicine Testing Product Portfolio
- 7.3.5 SGS Recent Developments
- 7.4 Lab Test One
- 7.4.1 Lab Test One Company Information
- 7.4.2 Lab Test One Business Overview
- 7.4.3 Lab Test One Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 Lab Test One Chinese Medicine Testing Product Portfolio
- 7.4.5 Lab Test One Recent Developments
- 7.5 CMA Testing
- 7.5.1 CMA Testing Company Information
- 7.5.2 CMA Testing Business Overview
- 7.5.3 CMA Testing Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 CMA Testing Chinese Medicine Testing Product Portfolio
- 7.5.5 CMA Testing Recent Developments
- 7.6 Agilent Technologies
- 7.6.1 Agilent Technologies Company Information
- 7.6.2 Agilent Technologies Business Overview
- 7.6.3 Agilent Technologies Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 Agilent Technologies Chinese Medicine Testing Product Portfolio
- 7.6.5 Agilent Technologies Recent Developments
- 7.7 Hong Kong Standards and Testing Centre
- 7.7.1 Hong Kong Standards and Testing Centre Company Information
- 7.7.2 Hong Kong Standards and Testing Centre Business Overview
- 7.7.3 Hong Kong Standards and Testing Centre Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 Hong Kong Standards and Testing Centre Chinese Medicine Testing Product Portfolio
- 7.7.5 Hong Kong Standards and Testing Centre Recent Developments
- 7.8 Nuherbs
- 7.8.1 Nuherbs Company Information
- 7.8.2 Nuherbs Business Overview
- 7.8.3 Nuherbs Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
- 7.8.4 Nuherbs Chinese Medicine Testing Product Portfolio
- 7.8.5 Nuherbs Recent Developments
8 North America
- 8.1 North America Chinese Medicine Testing Revenue (2021-2032)
- 8.2 North America Chinese Medicine Testing Revenue by Type (2021-2032)
- 8.2.1 North America Chinese Medicine Testing Revenue by Type (2021-2026)
- 8.2.2 North America Chinese Medicine Testing Revenue by Type (2027-2032)
- 8.3 North America Chinese Medicine Testing Revenue Share by Type (2021-2032)
- 8.4 North America Chinese Medicine Testing Revenue by Application (2021-2032)
- 8.4.1 North America Chinese Medicine Testing Revenue by Application (2021-2026)
- 8.4.2 North America Chinese Medicine Testing Revenue by Application (2027-2032)
- 8.5 North America Chinese Medicine Testing Revenue Share by Application (2021-2032)
- 8.6 North America Chinese Medicine Testing Revenue by Country
- 8.6.1 North America Chinese Medicine Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Chinese Medicine Testing Revenue by Country (2021-2026)
- 8.6.3 North America Chinese Medicine Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Chinese Medicine Testing Revenue (2021-2032)
- 9.2 Europe Chinese Medicine Testing Revenue by Type (2021-2032)
- 9.2.1 Europe Chinese Medicine Testing Revenue by Type (2021-2026)
- 9.2.2 Europe Chinese Medicine Testing Revenue by Type (2027-2032)
- 9.3 Europe Chinese Medicine Testing Revenue Share by Type (2021-2032)
- 9.4 Europe Chinese Medicine Testing Revenue by Application (2021-2032)
- 9.4.1 Europe Chinese Medicine Testing Revenue by Application (2021-2026)
- 9.4.2 Europe Chinese Medicine Testing Revenue by Application (2027-2032)
- 9.5 Europe Chinese Medicine Testing Revenue Share by Application (2021-2032)
- 9.6 Europe Chinese Medicine Testing Revenue by Country
- 9.6.1 Europe Chinese Medicine Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Chinese Medicine Testing Revenue by Country (2021-2026)
- 9.6.3 Europe Chinese Medicine Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Chinese Medicine Testing Revenue (2021-2032)
- 10.2 China Chinese Medicine Testing Revenue by Type (2021-2032)
- 10.2.1 China Chinese Medicine Testing Revenue by Type (2021-2026)
- 10.2.2 China Chinese Medicine Testing Revenue by Type (2027-2032)
- 10.3 China Chinese Medicine Testing Revenue Share by Type (2021-2032)
- 10.4 China Chinese Medicine Testing Revenue by Application (2021-2032)
- 10.4.1 China Chinese Medicine Testing Revenue by Application (2021-2026)
- 10.4.2 China Chinese Medicine Testing Revenue by Application (2027-2032)
- 10.5 China Chinese Medicine Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Chinese Medicine Testing Revenue (2021-2032)
- 11.2 Asia Chinese Medicine Testing Revenue by Type (2021-2032)
- 11.2.1 Asia Chinese Medicine Testing Revenue by Type (2021-2026)
- 11.2.2 Asia Chinese Medicine Testing Revenue by Type (2027-2032)
- 11.3 Asia Chinese Medicine Testing Revenue Share by Type (2021-2032)
- 11.4 Asia Chinese Medicine Testing Revenue by Application (2021-2032)
- 11.4.1 Asia Chinese Medicine Testing Revenue by Application (2021-2026)
- 11.4.2 Asia Chinese Medicine Testing Revenue by Application (2027-2032)
- 11.5 Asia Chinese Medicine Testing Revenue Share by Application (2021-2032)
- 11.6 Asia Chinese Medicine Testing Revenue by Country
- 11.6.1 Asia Chinese Medicine Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Chinese Medicine Testing Revenue by Country (2021-2026)
- 11.6.3 Asia Chinese Medicine Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Chinese Medicine Testing Revenue (2021-2032)
- 12.2 SAMEA Chinese Medicine Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Chinese Medicine Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Chinese Medicine Testing Revenue by Type (2027-2032)
- 12.3 SAMEA Chinese Medicine Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Chinese Medicine Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Chinese Medicine Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Chinese Medicine Testing Revenue by Application (2027-2032)
- 12.5 SAMEA Chinese Medicine Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Chinese Medicine Testing Revenue by Country
- 12.6.1 SAMEA Chinese Medicine Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Chinese Medicine Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Chinese Medicine Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst